🔔 Fundraising Alert
Wockhardt launches QIP at a floor price of Rs 1,162.25 to raise Rs 1,000 crore, expected to dilute equity by 5.57%.
Wockhardt Ltd Performance
Day's High
₹1,206.35₹1,25552 Week's Low
52 Week's High
₹232.4₹1,318.8
| Returns % | |
| 1 Month Return | + 35.09 % |
| 3 Month Return | + 42.66 % |
| 1 Year Return | + 429.32 % |
| Market Stats | |
| Previous Close | ₹1,269.85 |
| Open | ₹1,225.00 |
| Volume | 7.43L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹19,482.36Cr |
Wockhardt Ltd Key Statistics
| P/E Ratio | -53.56 |
| PEG Ratio | -2.72 |
| Market Cap | ₹19,482.36 Cr |
| P/B Ratio | 5 |
| EPS | -30.65 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 0 |
Wockhardt Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹19,482.36 Cr | 71.5% | 0.77 | -₹472 Cr | ₹2,798 Cr | |
| HOLD | ₹33,703.13 Cr | 137.12% | 0.52 | ₹300 Cr | ₹1,051 Cr | |
| BUY | ₹19,854.36 Cr | 33.47% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
| NA | ₹6,965.21 Cr | 6.09% | 0.79 | -₹388 Cr | ₹75 Cr | |
| BUY | ₹15,940.57 Cr | 49.73% | 0.68 | ₹218 Cr | ₹1,296 Cr |
Wockhardt Ltd Mutual Fund Holdings
About Wockhardt Ltd
Share Price: ₹1206.35 per share as on 07 Nov, 2024 04:01 PM
Market Capitalisation: ₹19,482.36Cr as of today
Revenue: ₹739.00Cr as on June 2024 (Q2 24)
Net Profit: ₹-16.00Cr as on June 2024 (Q2 24)
Listing date: 23 Feb, 2000
Chairperson Name: H F Khorakiwala
| Organisation | Wockhardt Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
What's happening today
Today's Timeline - 07 Nov
09:12 AM
-Wockhardt announces QIP launch at Rs 1,162.25 floor price to raise Rs 1,000 crore, with potential 5.57% equity dilution.
Key events for Wockhardt Ltd
Wockhardt Launches QIP, Stock Faces Pressure - 07 Nov, 2024
Wockhardt launched a Qualified Institutional Placement (QIP) at a discounted floor price, aiming to raise Rs 1,000 crore. The stock fell sharply due to investor concerns over equity dilution.
Wockhardt Stock Soars on New Antibiotic Approval News - 02 Nov, 2024
Wockhardt shares hit an 8-year high, surging 384% since November 2023. The rise is attributed to the announcement of its novel antibiotic Miqnaf™ and Aspart insulin submission for approval, indicating strong future growth potential.
Wockhardt Stock Surges Amid New Antibiotic Success - 01 Nov, 2024
Wockhardt's stock has surged fivefold this year, driven by the success of its latest antibiotic drug. Despite a decade of underperformance, the company is attracting interest from mutual funds and high-profile investors, raising hopes for a turnaround.
Wockhardt's Drug Development Leads to Stock Surge - 30 Oct, 2024
Wockhardt's stock has surged fivefold this year, attributed to a breakthrough drug developed over 25 years. The drug successfully treated a young cancer patient in the US, showcasing the company's perseverance in drug discovery.
Wockhardt Ltd Hits Upper Circuit on Positive Developments - 24 Oct, 2024
Wockhardt Ltd's stock reached a 5% upper circuit at ₹1,124.15 following favorable recommendations for its novel antibiotics. The company has seen a 397% increase in shares over the past year.
Wockhardt Shares Surge on Insulin Filing News - 16 Oct, 2024
Wockhardt Ltd's shares surged after the company filed for regulatory approval of its fast-acting insulin analog, ASPARAPID, with the DCGI. The filing highlights Wockhardt's capabilities in biosimilar development and aims to enhance diabetes care solutions. The stock reached an eight-year high, reflecting strong market interest and potential growth in the diabetes treatment sector.
Wockhardt Ltd Hits Upper Circuit on Positive News - 15 Oct, 2024
Wockhardt Ltd's stock reached a 5% upper circuit at ₹1,091.65 following favorable recommendations for its novel antibiotics. The company has seen a 330% increase in shares over the past year.
Wockhardt Stock Surges on Antibiotic Approval News - 14 Oct, 2024
Wockhardt Ltd's stock hit a 5% upper circuit after receiving a positive recommendation from CDSCO for its antibiotic Miqnaf, aimed at treating community-acquired bacterial pneumonia. The stock has gained 293% over the past year.
Wockhardt Awaits Approval for Pneumonia Treatment - 11 Oct, 2024
Wockhardt received a favorable recommendation from CDSCO for its antibiotic Miqnaf, targeting community-acquired bacterial pneumonia. The company expects approval soon, with significant market potential in India.
Wockhardt Shares Surge After USFDA Approval - 10 Oct, 2024
Wockhardt shares rose significantly after receiving USFDA approval for antibiotic Cefprozil tablets, reaching a high of Rs 399 during trading. The stock saw increased activity with 50,486 shares traded.
Insights on Wockhardt Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 2.91% to 2.95% in Sep 2024 quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, WOCKPHARMA stock has moved up by 35.1%
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, WOCKPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, WOCKPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 5.92% to 6.69% in Sep 2024 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -169.0 Cr → -14.0 Cr (in ₹), with an average increase of 1107.1% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 709.0 Cr → 769.0 Cr (in ₹), with an average increase of 4.0% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 51.99% of holdings in Sep 2024 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 37.61% to 36.21% in Sep 2024 quarter
Wockhardt Ltd Financials
Index Inclusions
Wockhardt Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 51.99% | ||
| Foreign Institutions | 6.69% | 12.90 | |
| Mutual Funds | 2.95% | 1.41 | |
| Retail Investors | 36.21% | ||
| Others | 2.16% | 38.41 |
Wockhardt Ltd Key Indicators
Wockhardt Ltd Valuation
Wockhardt Ltd in the last 5 years
Lowest (-94.57x)
October 8, 2021
Today (-53.56x)
November 6, 2024
Industry (57.15x)
November 6, 2024
Highest (12.70x)
May 26, 2021
Wockhardt Ltd Earnings and Dividends
Wockhardt Ltd Earnings Results
Wockhardt Ltd’s net profit jumped 89.55% since last year same period to ₹-14Cr in the Q1 2024-2025. On a quarterly growth basis, Wockhardt Ltd has generated 91.72% jump in its net profits since last 3-months.
Read More about Earnings ResultsWockhardt Ltd Dividends November,2016
In the quarter ending September 2016, Wockhardt Ltd has declared dividend of ₹10 - translating a dividend yield of 0.79%.
Read More about Dividends
Wockhardt Ltd Technicals Summary
Bearish
Neutral
Bullish
Wockhardt Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Wockhardt Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Wockhardt Ltd shares.
Wockhardt Ltd (WOCKPHARMA) share price today is ₹1206.35
Wockhardt Ltd is listed on NSE
Wockhardt Ltd is listed on BSE
- Today’s highest price of Wockhardt Ltd is ₹1255.
- Today’s lowest price of Wockhardt Ltd is ₹1206.35.
PE Ratio of Wockhardt Ltd is -53.56
PE ratio = Wockhardt Ltd Market price per share / Wockhardt Ltd Earnings per share
Today’s traded volume of Wockhardt Ltd(WOCKPHARMA) is 7.43L.
Today’s market capitalisation of Wockhardt Ltd(WOCKPHARMA) is ₹19482.36Cr.
| Wockhardt Ltd(WOCKPHARMA | Price |
|---|---|
52 Week High | ₹1318.8 |
52 Week Low | ₹232.4 |
Wockhardt Ltd(WOCKPHARMA) share price is ₹1206.35. It is down -8.53% from its 52 Week High price of ₹1318.8
Wockhardt Ltd(WOCKPHARMA) share price is ₹1206.35. It is up 419.08% from its 52 Week Low price of ₹232.4
| Wockhardt Ltd(WOCKPHARMA | Returns |
|---|---|
1 Day Returns | -63.5% |
1 Month Returns | 35.09% |
3 Month Returns | 42.66% |
1 Year Returns | 429.32% |